ASO Author Refections: The potential role of particle therapy as a therapeutic option for patients with recurrent hepatocellular carcinoma after liver resection.

Autor: Kusuhara T; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan., Gon H; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan. hidetoshi541128@gmail.com., Terashima K; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan., Komatsu S; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan., Matsuo Y; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan., Tokumaru S; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan., Toyama H; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan., Kido M; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan., Okimoto T; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan., Fukumoto T; Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Jazyk: angličtina
Zdroj: Annals of surgical oncology [Ann Surg Oncol] 2025 Jan; Vol. 32 (1), pp. 448-449. Date of Electronic Publication: 2024 Oct 26.
DOI: 10.1245/s10434-024-16430-2
Abstrakt: Competing Interests: Disclosures: The authors have no conflict of interest or financial ties to disclose.
Databáze: MEDLINE
Externí odkaz: